Vistagen Therapeutics Inc (VTGN): Next-Year EPS Estimate 38.39%
As of 2026-06-11, Vistagen Therapeutics Inc (VTGN) has a next-year EPS growth estimate of 38.39%.
On 2026-05-10, analyst consensus for VTGN's next-year EPS growth shifted from 38.37% to 38.39% — a positive change of 0.02 percentage points. The revised estimate has been sustained across 25 subsequent trading sessions. Current-year growth is projected at -6.59%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 38.39%
- EPS growth this year
- -6.59%
- EPS next quarter (est)
- -$0.34
- Last price
- $0.57
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 38.39% | -6.59% | -$0.34 | $0.57 |
| 2026-06-10 | 38.39% | -6.59% | -$0.34 | $0.54 |
| 2026-06-09 | 38.39% | -6.59% | -$0.34 | $0.54 |
| 2026-06-08 | 38.39% | -6.59% | -$0.34 | $0.54 |
| 2026-06-07 | 38.39% | -6.59% | -$0.34 | $0.54 |
| 2026-06-04 | 38.39% | -6.59% | -$0.34 | $0.58 |
| 2026-06-03 | 38.39% | -6.59% | -$0.34 | $0.56 |
| 2026-06-02 | 38.39% | -6.59% | -$0.34 | $0.58 |
| 2026-06-01 | 38.39% | -6.59% | -$0.34 | $0.65 |
| 2026-05-31 | 38.39% | -6.59% | -$0.34 | $0.63 |
| 2026-05-28 | 38.39% | -6.59% | -$0.34 | $0.63 |
| 2026-05-27 | 38.39% | -6.59% | -$0.34 | $0.62 |
| 2026-05-26 | 38.39% | -6.59% | -$0.34 | $0.64 |
| 2026-05-25 | 38.39% | -6.59% | -$0.34 | $0.65 |
| 2026-05-24 | 38.39% | -6.59% | -$0.34 | $0.65 |
| 2026-05-21 | 38.39% | -6.59% | -$0.34 | $0.64 |
| 2026-05-20 | 38.39% | -6.59% | -$0.34 | $0.64 |
| 2026-05-19 | 38.39% | -6.59% | -$0.34 | $0.63 |
| 2026-05-18 | 38.39% | -6.59% | -$0.34 | $0.60 |
| 2026-05-17 | 38.39% | -6.59% | -$0.34 | $0.62 |
| 2026-05-14 | 38.39% | -6.59% | -$0.34 | $0.65 |
| 2026-05-13 | 38.39% | -6.59% | -$0.34 | $0.66 |
| 2026-05-12 | 38.39% | -6.59% | -$0.34 | $0.62 |
| 2026-05-11 | 38.39% | -6.59% | -$0.34 | $0.67 |
| 2026-05-10 | 38.39% | -6.59% | -$0.34 | $0.61 |
| 2026-05-07 | 38.37% | -6.55% | -$0.34 | $0.59 |
| 2026-05-06 | 38.37% | -6.55% | -$0.34 | $0.61 |
| 2026-05-05 | 38.37% | -6.55% | -$0.34 | $0.60 |
| 2026-05-04 | 38.37% | -6.55% | -$0.34 | $0.62 |
| 2026-05-03 | 38.37% | -6.55% | -$0.34 | $0.63 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Vistagen Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Vistagen Therapeutics Inc (VTGN) has a next-year EPS growth estimate of 38.39%, based on analyst consensus.
When was the latest EPS estimate revision for VTGN?▾
The most recent revision occurred on 2026-05-10, when analysts adjusted the next-year EPS growth estimate from 38.37% to 38.39%.
What sector and industry does Vistagen Therapeutics Inc belong to?▾
Vistagen Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. VTGN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Vistagen Therapeutics Inc (VTGN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports